Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.

Diagnostics (Basel) · 2021 · PMC7924191 · PMID 33672622

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

For HMGB1, slightly significant prognostic value was seen before cycle 2, but a strong difference between prognostic groups was observed prior to cycle 3.

also in 1,750 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.